Our Contributors
Latest from BioTech Health X
- Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024
- Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024
- Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue
- Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results
- Lakeside (LSH) Partners with Huiyu Pharmaceutical to Expand Global Oncology Drug Distribution
- Sanara MedTech (SMTI) Achieves Record $21.7M Revenue in Q3 2024